EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Mitochondrial Quality Control and Apoptotic Thresholds in Major Depressive Disorder: A Structured Narrative Review

Caiyan Hou, Zhixiang Li iD, Dingren Niu, Wei Zou iD

Neuropsychiatric Disease and Treatment · 2026-11 · Volume 22 · 1-34

DOI: 10.2147/ndt.s639235 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2026-11. Verfasst von Caiyan Hou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is clinically heterogeneous, and many patients do not achieve sustained remission with monoaminergic treatments. Mitochondrial dysfunction has been associated with chronic stress, impaired synaptic function, altered cellular energetics, and neuronal vulnerability, but evidence concerning mitochondrial dynamics, mitophagy, redox imbalance, calcium signaling, and intrinsic apoptosis remains distributed across experimental systems. This structured narrative review integrates human brain and peripheral studies, patient-derived cellular evidence, animal models, and general cell biology. We propose the mitochondrial quality control-mitochondrial outer membrane permeabilization (MQC-MOMP) threshold model as a conceptual framework, not an experimentally established disease mechanism. In this model, cumulative failure of mitochondrial repair and clearance may shift stress responses toward Bax/Bak-dependent MOMP and caspase activation. Human findings are largely associative and do not establish widespread mitochondria-driven neuronal apoptosis in living patients with MDD; mechanistic support is strongest in preclinical and cellular models. The framework therefore differs from prior topic-based reviews by organizing heterogeneous evidence according to evidence source, certainty, and proximity to clinical translation. Here we highlight testable priorities for biomarker validation, patient stratification, cell-type-resolved studies, longitudinal cohorts, and mechanism-based interventions.

Schlagwörter

Stichwörter der Autor:innen

PINK1/Parkin pathwaybax/bcl-2major depressive disordermitochondrial apoptosismitophagyoxidative stress

Autor:innen und Institutionen

  • Graduate School, Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China.
  • Xuzhou Central Hospital, Southeast University, Xuzhou, People's Republic of China.
  • Acupuncture and Moxibustion Department (III), The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China.

ORCID-Profile: Zhixiang Li, Wei Zou

Zitieren

APA

Hou, C., Li, Z., Niu, D., & Zou, W. (2026). Mitochondrial Quality Control and Apoptotic Thresholds in Major Depressive Disorder: A Structured Narrative Review. Neuropsychiatric Disease and Treatment, Volume 22, 1-34. https://doi.org/10.2147/ndt.s639235

Vancouver

Hou C, Li Z, Niu D, Zou W. Mitochondrial Quality Control and Apoptotic Thresholds in Major Depressive Disorder: A Structured Narrative Review. Neuropsychiatric Disease and Treatment. 2026;Volume 22:1-34. doi:10.2147/ndt.s639235

BibTeX
@article{Hou2026,
  author = {Hou, Caiyan and Li, Zhixiang and Niu, Dingren and Zou, Wei},
  title = {Mitochondrial Quality Control and Apoptotic Thresholds in Major Depressive Disorder: A Structured Narrative Review},
  journal = {Neuropsychiatric Disease and Treatment},
  year = {2026},
  volume = {Volume 22},
  pages = {1--34},
  doi = {10.2147/ndt.s639235}
}
Kostenlos starten →